Robert Boyle

Has grant

Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Trial of IgE tests for Eczema Relief (TIGER)

Open Date: 2022-08-01

Close Date: 2025-11-01

Grant: Close

Development and feasibility testing of an intervention to prevent potentially harmful skincare practices during infancy

Open Date: 2022-04-01

Close Date: 2024-10-01

Grant: Close

Systematic review and network meta-analysis of topical anti-inflammatory treatments for eczema

Open Date: 2021-08-01

Close Date: 2023-08-01

Grant: Close

Cochrane Review: interventions for hyperhidrosis

Open Date: 2021-07-01

Close Date: 2022-12-01

Grant: Close

Systematic review of phototherapy for treating eczema

Open Date: 2020-09-01

Close Date: 2021-08-01

Articles (10)

Year:

2023

India is a low‐middle income country with a population of 1.4 billion and home to one quarter of the world's children. Exclusive breastfeeding until 6 months and continued breastfeeding until at least 2 years as per global recommendations are common practice. The Indian government and associated organisations have strived to protect breastfeeding, which is important in a country with high under‐5 mortality, malnutrition and stunting. Allergic disease is under‐recognised in India, but despite the absence of a dedicated allergy medical specialty, awareness of allergy is increasing among healthcare practitioners and in the general population. In high‐income countries, overdiagnosis of allergy has become recognised as an issue in recent years. Allergy healthcare professionals have also attracted criticism for close relationships with the formula industry, which appear to have contributed to excessive use of specialised formula products and undermining of breastfeeding. Specialised formula has been used unnecessarily for preventing allergy, based on fraudulent and selectively reported science; and for managing normal infant symptoms which are mislabelled as milk allergy. This forms part of a broader formula industry corporate strategy to widen the boundaries of illness in order to expand sales and markets. In India, allergic disease management is hindered by limited understanding of the disease entity among practitioners, low access to diagnostics, limited healthcare resources, high exposure to air pollution and a large, diverse population. Data specific to India on allergic disease prevalence and interpreting allergy diagnostics are incomplete. The knowledge gaps mean allergy management in India is often extrapolated from guidance developed in high‐income countries with low breastfeeding rates. As the allergy specialty develops in India, local guidance and practice will need to recognise the threat that current allergy practice poses to India's normative infant feeding culture, and ensure that breastfeeding continues to be supported at all levels.

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Andreina Marques-Mejias

King’s College London

UNITED KINGDOM
View details

Jayanta Banerjee

Neonatal Consultant and Hon Senior Clinical Lecturer

Imperial College Healthcare NHS Trust

UNITED KINGDOM
View details

valerie verhasselt

University of Western Australia

AUSTRALIA
View details

Eefje de Bont

Assistant Professor and GP

Maastricht University Medical Centre

NETHERLANDS
View details

Lars K. Poulsen

Københavns Universitet

DENMARK
View details

Alison McFadden

Professor of Mother and Infant Public Health

University of Dundee

UNITED KINGDOM
View details

Michael Perkin

Reader in Clinical Epidemiology & Honorary Consultant in Paediatric Allergy

St George’s, University of London

UNITED KINGDOM
View details

Mary Feeney

King’s College London

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.